Endocrinology, Vol 133, 312-320, Copyright © 1993 by Endocrine Society

ARTICLES

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system

JM Reul, I Stec, M Soder and F Holsboer
Max Planck Institute of Psychiatry, Department of Neuroendocrinology, Munich, Germany.

The effects of the tricyclic antidepressant amitriptyline on the rat hypothalamic-pituitary-adrenocortical (HPA) system were studied. The time-course experiments showed that amitriptyline, given via the drinking water (4.5 mg/kg.day), produces significant decreases (P < 0.05) in adrenal weight after 5 (-20%) and 7 weeks (-21%) of treatment. Hippocampal mineralocorticoid receptor (MR) levels were down-regulated at days 3 (-27%) and 7 (-20%), and transiently up-regulated at 2 (+40%), 5 (+74%), and 7 (+18%) weeks of treatment. Hippocampal glucocorticoid receptor (GR) levels were slightly down-regulated at days 3 (-8%) and 7 (-17%), transiently up-regulated by 26% at 5 weeks, and indistinguishable from controls after 7 weeks of treatment. MR levels were unchanged in the hypothalamus and neocortex, whereas hypothalamic GR concentrations were elevated and neocortical receptor levels were not altered. Dose-response experiments showed significant decreases in adrenal weight when rats were treated with 4.5 (-14%), 8.8 (-16%) and 14.5 (-13%) mg/kg.day antidepressant, but this applied only for the 4.5- (-14%) and 8.8- (-12%) mg/kg.day doses when the ratio of adrenal weight to body weight was considered. The dose-response relationship regarding hippocampal GR content displayed an inverted U- shaped curve, whereas this was less marked for MR levels. A dose of 4.5 mg/kg.day appeared to be optimal for the rise in MR as well as GR. Concerning the neuroendocrine implications of chronic antidepressant treatment, amitriptyline (5 weeks, 4.5 mg/kg.day) produced significant decreases in basal (ACTH, -47%; corticosterone, -31%) as well as stress (30 min novel environment)-induced plasma ACTH (-38%) and corticosterone (-57%) levels. Previous experiments have forwarded a role of limbic MR in the tonic control of basal HPA activity. Based on the present data, we hypothesize that during amitriptyline treatment a rise in limbic MR may be the initial phenomenon in a successively adjusting HPA system, as evidenced by the decreasing plasma hormone concentrations, declining adrenal size, and up-regulation of GR in particular brain regions.

This article has been cited by other articles:

				M. P. Boyle, J. A. Brewer, M. Funatsu, D. F. Wozniak, J. Z. Tsien, Y. Izumi, and L. J. Muglia Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior PNAS, January 11, 2005; 102(2): 473 - 478. [Abstract] [Full Text] [PDF]

				H. Jahn, M. Schick, F. Kiefer, M. Kellner, A. Yassouridis, and K. Wiedemann Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial Arch Gen Psychiatry, December 1, 2004; 61(12): 1235 - 1244. [Abstract] [Full Text] [PDF]

				K. Mukherjee, A. Knisely, and L. Jacobson Partial Glucocorticoid Agonist-Like Effects of Imipramine on Hypothalamic-Pituitary-Adrenocortical Activity, Thymus Weight, and Hippocampal Glucocorticoid Receptors in Male C57BL/6 Mice Endocrinology, September 1, 2004; 145(9): 4185 - 4191. [Abstract] [Full Text] [PDF]

				S. K. Droste, A. Gesing, S. Ulbricht, M. B. Muller, A. C. E. Linthorst, and J. M. H. M. Reul Effects of Long-Term Voluntary Exercise on the Mouse Hypothalamic-Pituitary-Adrenocortical Axis Endocrinology, July 1, 2003; 144(7): 3012 - 3023. [Abstract] [Full Text] [PDF]

				B. A. Kalman and R. L. Spencer Rapid Corticosteroid-Dependent Regulation of Mineralocorticoid Receptor Protein Expression in Rat Brain Endocrinology, November 1, 2002; 143(11): 4184 - 4195. [Abstract] [Full Text] [PDF]

				S. C. Stout, M. J. Owens, and C. B. Nemeroff Regulation of Corticotropin-Releasing Factor Neuronal Systems and Hypothalamic-Pituitary-Adrenal Axis Activity by Stress and Chronic Antidepressant Treatment J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1085 - 1092. [Abstract] [Full Text] [PDF]

				J. L. W. Yau, J. Noble, C. Hibberd, W. B. Rowe, M. J. Meaney, R. G. M. Morris, and J. R. Seckl Chronic Treatment with the Antidepressant Amitriptyline Prevents Impairments in Water Maze Learning in Aging Rats J. Neurosci., February 15, 2002; 22(4): 1436 - 1442. [Abstract] [Full Text] [PDF]

				A. Gesing, A. Bilang-Bleuel, S. K. Droste, A. C. E. Linthorst, F. Holsboer, and J. M. H. M. Reul Psychological Stress Increases Hippocampal Mineralocorticoid Receptor Levels: Involvement of Corticotropin-Releasing Hormone J. Neurosci., July 1, 2001; 21(13): 4822 - 4829. [Abstract] [Full Text] [PDF]

				F. T. Bergh, T. Kümpfel, A. Grasser, R. Rupprecht, F. Holsboer, and C. Trenkwalder Combined Treatment with Corticosteroids and Moclobemide Favors Normalization of Hypothalamo-Pituitary-Adrenal Axis Dysregulation in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double Blind Trial J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1610 - 1615. [Abstract] [Full Text]

				R. McQUADE and A. H. Y. YOUNG Future therapeutic targets in mood disorders: the glucocorticoid receptor The British Journal of Psychiatry, November 1, 2000; 177(5): 390 - 395. [Abstract] [Full Text] [PDF]

				A. Stefferl, C. Linington, F. Holsboer, and J. M. H. M. Reul Susceptibility and Resistance to Experimental Allergic Encephalomyelitis: Relationship with Hypothalamic-Pituitary-Adrenocortical Axis Responsiveness in the Rat Endocrinology, November 1, 1999; 140(11): 4932 - 4938. [Abstract] [Full Text]

				M. M. Weber, C. Fottner, P. Schmidt, K. M. H. Brodowski, K. Gittner, H. Lahm, D. Engelhardt, and E. Wolf Postnatal Overexpression of Insulin-Like Growth Factor II in Transgenic Mice Is Associated with Adrenocortical Hyperplasia and Enhanced Steroidogenesis Endocrinology, April 1, 1999; 140(4): 1537 - 1543. [Abstract] [Full Text]

				E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls Brain Corticosteroid Receptor Balance in Health and Disease Endocr. Rev., June 1, 1998; 19(3): 269 - 301. [Abstract] [Full Text]

				G. E. Duncan, D. J. Knapp, S. W. Carson, and G. R. Breese Differential Effects of Chronic Antidepressant Treatment on Swim Stress- and Fluoxetine-Induced Secretion of Corticosterone and Progesterone J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 579 - 587. [Abstract] [Full Text]

				C. M. Pariante, B. D. Pearce, T. L. Pisell, M. J. Owens, and A. H. Miller Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine Mol. Pharmacol., October 1, 1997; 52(4): 571 - 581. [Abstract] [Full Text]

				S. Karanth, A. C. E. Linthorst, G. K. Stalla, N. Barden, F. Holsboer, and J. M. H. M. Reul Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function Endocrinology, August 1, 1997; 138(8): 3476 - 3485. [Abstract] [Full Text] [PDF]